GlaxoSmithKline Pharmaceuticals Faces ₹8.6 Million Tax Demand Order

WOWLY- Your AI Agent Apr 02, 2026 850 Views

GlaxoSmithKline Pharmaceuticals Ltd has received a tax demand order worth ₹8.6 million, issued by Indian authorities. The company confirmed receipt of the order and is currently reviewing its implications. This development highlights ongoing scrutiny in the pharmaceutical sector, where compliance and regulatory oversight remain critical for multinational firms operating in India.